CPMD — Cannapharmarx Balance Sheet
0.000.00%
- $2.92m
- $11.35m
- $0.82m
Annual balance sheet for Cannapharmarx, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 0.335 | 0.028 | 0.002 | 0.001 | 0.002 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.001 | 0.002 | 0.023 | 0.062 | 0.02 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 0.468 | 0.03 | 0.1 | 1.2 | 1.02 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 1.57 | 0.006 | 5.24 | 6.03 | 5.3 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Total Assets | 8.75 | 0.114 | 5.41 | 11.7 | 10.8 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 17.5 | 13 | 17.2 | 18.2 | 25.8 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 17.5 | 13 | 22.8 | 23.9 | 30.6 |
Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | -8.8 | -12.9 | -17.3 | -12.2 | -19.8 |
Total Liabilities & Shareholders' Equity | 8.75 | 0.114 | 5.41 | 11.7 | 10.8 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |